It has been argued that one reason underlying the rapid spread of HIV among women is that, with the possible exception of the female condom, no reliable HIV/sexually transmitted disease (STD) prevention method is available that women can use without their partner's consent. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] This has led to a call within the health care community for the development of more "femalecontrolled" methods of HIV/STD prevention. But this assumes that female control is an important and personally desirable feature for sexually active women and, moreover, that women who are currently not using an HIV/STD prevention method would do so if female-controlled methods were available. The present research attempts to determine the level of interest in female-controlled methods of HIV/STD prevention.
Methods

Respondents
Interviews were conducted with 168 African American women between 18 and 32 years of age who had had at least 3 sexual partners in the past 2 years and at least 1 incident of unprotected sex. (Copies of the complete survey instrument, as well as more detailed sampling information, can be obtained from the authors on request.) These criteria were selected to ensure that our sample had at least a moderate level of risk of HIV/STD transmission from a heterosexual partner.
Data Collection
Importance of female control. Respondents were asked to rate, on a scale from 1 to 10, how important each of 44 features was to them personally. Of particular interest was the item "How important for HIV prevention is it to you that you use a method that YOU can control (you either wear it or apply it)?" Sexual history. Respondents were asked at what age they became sexually active; how many sexual partners they had in the past month, in the past year, and in their lifetime; and how frequently they had had sex in the past month and the past year. History of STDs also was assessed.
Methods of HIV and pregnancy prevention. Respondents were asked to rate, on a 7-point scale that ranged from never (0%) to absolutely every time (100%), how frequently they used condoms with their most recent partner. They also were asked if they had "ever" used each of the following 16 methods: abstinence, rhythm, female condom, the pill, the sponge, withdrawal, male condoms, oral sex, spermicide, Norplant, diaphragm, Depo-Provera, tubal ligation, intrauterine device, douching, and male sterilization (yes or no) and whether they would consider using each method in the future (on a 10-point scale).
Demographics. Information on age, education level, and income of the respondents was gathered.
Results
Importance of Female Control as a Feature of an HIV Prevention Method
The item "How important for HIV prevention is it to you that you use a method that YOU can control (you either wear it or apply it)?" resulted in a mean value of 7.30 (SD= 2.96). In terms of relative importance, 21 of the 44 items received higher ratings.
Responses to this item, however, were not normally distributed. Rather, the majority of respondents fell into 1 of 2 groups: (1) women with a high desire for a female-controlled method (HDFM) (i.e., those who rated female control as 9 or 10 on a 10-point scale [n = 71, 42%; mean = 9.93]), and (2) women with a low desire for a femalecontrolled method (LDFM) (i.e., those who rated female control as 6 or less [n = 60, 
Comparisons of HDFM and LDFM Women
Sexual history. The t tests revealed that HDFM women, who rated female control as relatively important to them in their selection of an HIV/STD prevention method, initiated sex at a significantly later age than their LDFM counterparts (t 111 = 1.80, P = .04). As indicated in Table 1 , HDFM women also tended to have significantly fewer sex partners than LDFM women in the past month (t 113 = 1.78, P = .05), in the past year (t 117 = 1.94, P = .01), and in their lifetime (t 120 = 2.40, P = .01). However, no significant difference was found in the frequency of sex between the 2 groups during the past month (t 123 = 1.50, P = .12) or the past year (t 116 = 0.86, P = .39).
A statistically significant difference did emerge, however, in reported frequency of condom use, with HDFM women reporting more frequent male condom use with their most recent partner than did their LDFM counterparts (t 120 = 4.48, P < .001). This differential frequency of condom use parallels a differential STD rate, with LDFM women reporting signif icantly higher rates of syphilis (t 126 = 3.08, P < .001), gonorrhea (t 126 = 1.79, P < .05), and herpes (t 126 = 1.75, P< .04).
As shown in Table 2 , HDFM women were more likely than LDFM women to have used oral sex instead of vaginal sex, abstinence, tubal ligation, Depo-Provera, the sponge, and the female condom at least once in the past. HDFM women also expressed significantly more willingness to consider using the female condom (t 115 = 3.43, P < . 
Discussion
Of 44 potential features for HIV/STD prevention, a method that a woman can control by either wearing or applying it ranked 22nd in relative importance. Other features, such as safety, effectiveness, availability, and ease of use, were rated as more central to our respondents' choice of prevention method.
HDFM women generally appear to be at lower risk for contracting HIV than LDFM women. More specifically, HDFM women reported significantly lower rates of syphilis, gonorrhea, and herpes. HDFM women also had significantly fewer sex partners in the past month, in the past year, and in their lifetime. However, the 2 groups did not differ in terms of frequency of sex, suggesting that HDFM women may be involved in longer-term relationships with fewer men.
Further analyses revealed that HDFM women were approximately twice as likely to have used a variety of HIV/STD prevention methods, including oral sex in place of anal or vaginal sex, abstinence, the sponge, and the female condom, at least once. Ironically, HDFM women were significantly more likely to be currently using or to consider using male condoms, a method often criticized as being controlled by the male partner. Moreover, HDFM women were sig- Note. STD = sexually transmitted disease. *P < .10; **P < .05; ***P < .01. Odds ratios of 1.0 imply no significant difference between the 2 groups. Values > 1.0 indicate the ratio by which women with high desire for a female-controlled method are more likely than women with low desire for a female-controlled method to use a method. Values < 1.0 indicate the extent to which women with high desire for a female-controlled method are less likely than women with low desire for a female-controlled method to use a particular prevention method. *P < .10; **P < .05; ***P < .01.
Briefs
nificantly more willing to consider using abstinence, oral sex, the sponge, and the female condom in the future. In other words, it appears that although the HDFM women may desire additional female-controlled HIV prevention methods, they are nevertheless willing and able to avail themselves of currently existing methods.
In summary, although female control may be of interest to a substantial percentage of women in their selection of an HIV/STD prevention method, it may, ironically, be of less interest to those most at risk. These data underscore the need to take the priorities and preferences of women into consideration when developing new prevention methods.
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